Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
The Annals of Pharmacotherapy|March 16, 2002
Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniaeMichael B Kays, Melissa A GraffJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 23, 2002
Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasmaHairui Liang, Michael B Kays, Kevin M SowinskiInternational Journal of Antimicrobial Agents|January 24, 2007
Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodologyMichael B Kays, Christopher R Lisek, Gerald A DenysJournal of Clinical Pharmacology|February 27, 2016
Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapySusan J Lewis, Michael B Kays, Bruce A MuellerJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 25, 2003
Determination of gatifloxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detectionBrian R Overholser, Michael B Kays, Kevin M SowinskiJournal of Clinical Pharmacology|August 20, 2004
Sex-related differences in the pharmacokinetics of oral ciprofloxacinBrian R Overholser, Michael B Kays, Alan Forrest, et al.Journal of Clinical Pharmacology|September 22, 2006
Gatifloxacin pharmacokinetics in healthy men and womenXin Zhang, Brian R Overholser, Michael B Kays, et al.Diagnostic Microbiology and Infectious Disease|June 29, 2002
Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutationMichael B Kays, Matthew F Wack, David W Smith, et al.The Annals of Pharmacotherapy|February 8, 2017
Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized PatientsEun Kyoung Chung, Megan R Fleming, S Christian Cheatham, et al.Clinical Therapeutics|June 5, 2012
System-wide implementation of the use of an extended-infusion piperacillin/tazobactam dosing strategy: feasibility of utilization from a children's hospital perspectiveKristen R Nichols, Chad A Knoderer, Elaine G Cox, et al.Pageof 3